Mariana Oncology Inc.

About Mariana Oncology Inc.

Mariana Oncology, a Novartis company, is focused on pioneering precision radioligand therapies to revolutionize cancer treatment. Their mission is to optimize efficacy while improving the treatment journey for patients by minimizing the impact on healthy tissue.

Products & Services

Precision Radioligand Therapies:A new generation of therapies designed to selectively deliver radioisotopes to diseased cells, targeting challenging cancers with minimal impact on healthy tissue.

Specialties

Radioligand Therapies Precision Cancer Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 175000000 MR: - FA: 175 million FAN: 175000000	D: 2023-09-07 FD: 2023-09-07	8 investors

Series B Latest

2023-09-07

$175.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Fred Zecri

Chief Scientific Officer - Site Head

G

Gökben Koca

Chief Medical Officer

C

Caroline Breitbach

SVP, Asset & Portfolio Leadership

M

Melissa Vasbinder

Head of Research

T

Travis Tirrell

Head of Legal & Business Operations

B

Bill Diamantopoulos

Chief Technology Officer

View 8 more team members with Pro

Unlock Full Team Directory

Recent News